Single Rising Dose Trial of BI 425809 for Healthy Japanese and Chinese Male Subjects

NCT02383888 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

49

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: BI 425809
DRUG: Placebo

Sponsor

Boehringer Ingelheim